New research offers hope as Ebola outbreak affects Congo

The Democratic Republic of Congo is facing a major Ebola outbreak caused by the rare Bundibugyo strain of the virus, Deutsche Welle reported. There is currently no approved vaccine against this specific strain. New scientific research has raised hopes for developing broader protection against multiple types of the virus. [1]

According to Deutsche Welle, the first scientifically documented Ebola epidemic occurred 50 years ago in 1976 near the Ebola River in the country then known as Zaire. The Bundibugyo strain itself was first identified in 2007 during an outbreak in Uganda. [1]

The 2026 epidemic is the 17th Ebola outbreak in the Democratic Republic of Congo, with initial cases reported on 14 May 2026 in Ituri Province. Early infections likely began in early 2026 in the town of Mongbwalu. By early August, it became the fastest growing Ebola outbreak on record and the second largest overall. [2]

Ebola virus disease symptoms typically begin after an incubation period of 2 to 21 days following exposure. Initial symptoms include high fever, severe headache, muscle pain, fatigue, and sore throat, followed by gastrointestinal issues such as vomiting and watery diarrhea within 3 to 5 days. [3]